Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Details Narrative)

v3.22.1
Notes Payable (Details Narrative) - Bridge Loan Note [Member] - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Nov. 11, 2020
MyMD Pharmaceuticals (Florida), Inc [Member]      
Short-Term Debt [Line Items]      
Advances to Affiliate $ 3,000,000 $ 3,000,000  
Interest Receivable   26,137  
Notes Receivable, Related Parties $ 3,026,137 $ 3,026,137  
Merger Agreement [Member]      
Short-Term Debt [Line Items]      
Maximum principal amount     $ 3,000,000
Interest rate     5.00%
Merger Agreement [Member] | Event of Default [Member]      
Short-Term Debt [Line Items]      
Interest rate     8.00%